255
Views
22
CrossRef citations to date
0
Altmetric
Research Article

The AKT1 gene is associated with attention and brain morphology in schizophrenia

, , , , , , , , , , , , , , , , , , , , & show all
Pages 100-113 | Received 24 Dec 2010, Accepted 24 May 2011, Published online: 12 Dec 2011
 

Abstract

Objectives. A meta-analysis of the associations between genetic variants in the AKT1 gene and schizophrenia found that a single nucleotide polymorphism (SNP5; rs2494732) was associated with schizophrenia in Asian populations. Methods. In this study, we investigated the effects of this SNP on memory and attentional performance and brain structure using magnetic resonance imaging in a Japanese population (117 patients with schizophrenia and 189 healthy subjects). Results. The memory performance, particularly attention/concentration score, measured by the Wechsler Memory Scale-Revised in A carriers of SNP5, which was found to be enriched in patients with schizophrenia, was lower than that in individuals with the G/G genotype. We confirmed the association of the SNP with attentional performance using the Continuous Performance Test, which assessed sustained attention and vigilance of attentional function. Patients with A allele demonstrated lower attentional performance than patients with the G/G genotype. Patients with the A allele had smaller gray matter volumes in the right inferior parietal lobule related to attentional processes and in the frontostriatal region related to different SNPs in AKT1 than patients with the G/G genotype. Conclusions. Our results suggest that a genetic variant of AKT1 might be associated with attentional deficits and brain morphological vulnerability in patients with schizophrenia.

Acknowledgements

We thank all individuals who participated in this study. We also thank Louise Verrall for the English proofreading of the manuscript. This work was supported by Grants-in-Aid from the Japanese Ministry of Health, Labor and Welfare (H19-kokoro-002, Comprehensive Research on Disability Health and Welfare, and the Research Committee of System Development for Clinical Trials in Psychiatry and Neurology), the Japanese Ministry of Education, Culture, Sports, Science and Technology (18689030 and 22390225), the Core Research for Evolutionary Science and Technology of Japan Science and Technology Agency, Grant-aid for Scientific Research on Priority Areas -Research on Pathomechanisms of Brain Disorders from the MEXT (18023045) and Japan Foundation for Neuroscience and Mental Health.

Statement of interest

None to declare.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.